Appraisals - ASAR & FAR

31/07/2019

Appraisal Report: eltrompobag (Revolade) 2692

01/02/2021

Appraisal Report: dupilumab (Dupixent®) 3858

24/02/2020

Appraisal Report: doxylamine (Xonvea) 2170

01/09/2020

Appraisal Report: doravirine / lamivudine / tenofovir disoproxil fumarate (Delstrigo) 3648

28/08/2020

Appraisal Report: doravirine (Pifeltro) 3109

13/05/2019

Appraisal Report: dolutegravir / rilpivirine (Juluca) 2850

21/04/2020

Appraisal Report: dolutegravir / lamivudine (Dovato) 3659

12/10/2021

Appraisal Report: dolutegravir (Tivicay) 4611

25/07/2019

Appraisal Report: dolutegravir (Tivicay) 3373

25/07/2019

Appraisal Report: desmopressin acetate (Noqdirna) 3282

31/07/2019

Appraisal Report: dequalinium chloride (Fluomizin) 2775

26/06/2019

Appraisal Report: dasatinib (Sprycel) 1514

27/10/2020

Appraisal Report: darunavir/cobicistat (Rezolsta) 3779

17/05/2021

Appraisal Report: darunavir / cobicistat / emtricitabine / tenofovir alafenamide (Symtuza) 2418

26/02/2020

Appraisal Report: darunavir (Prezista) 2579

25/07/2019

Appraisal Report: dalbavancin (Xydalba) 2001

27/01/2022

Appraisal Report: clostridium botulinum (Dysport) 2626

25/07/2019

Appraisal Report: ciprofloxacin (Cetraxal) 1343

31/07/2019

Appraisal Report: cefuroxime (Aprokam) 2224

31/07/2019

Appraisal Report: ceftolozane/tazobactam (Zerbaxa) 2356